⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 24, 2024AgingOpen Access

Biological significance of METTL5 in atherosclerosis: comprehensive analysis of single-cell and bulk RNA sequencing data

Jianjin Wu Lei Wang Shuaishuai Xi Chao Ma Fukang Zou Guanyu Fang Fangbing Liu Xiaokai Wang Lefeng Qu

View Full Paper

Ask AI

Bookmark

Share

Abstract

N6-methyladenosine (m6A) methylation is involved in the pathogenesis of atherosclerosis (AS). Limited studies have examined the role of the m6A methyltransferase METTL5 in AS pathogenesis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2024) studied this question.

synapsesocial.com/papers/68e6dd4fb6db643587658d28 https://doi.org/10.18632/aging.205755

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The potential roles of RNA N6-methyladenosine in atherosclerosis.review · 2022 · 16 citations
2Redox-sensitive m6A regulation in atherosclerosis: METTL3 at the crossroads of mitochondrial quality control and pyroptosis2025
3The role of m6A methyltransferase METTL3 in metabolism-related diseases: mechanism and clinical implications2025 · 7 citations
4The novel <scp>m6A</scp> writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma2024 · 19 citations
5METTL4-Mediated Mitochondrial DNA N6-Methyldeoxyadenosine Promoting Macrophage Inflammation and Atherosclerosispreclinical · 2024 · 65 citations